36 filings
Page 2 of 2
6-K
09wg 92s1d
2 May 19
Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack
4:46pm
6-K
vnw4q7tq
29 Apr 19
Report of Foreign Private Issuer
4:29pm
6-K
ktyr1c48wdft0k
15 Apr 19
Report of Foreign Private Issuer
7:20am
6-K
w6oqs
12 Apr 19
Report of Foreign Private Issuer
4:04pm
6-K
idmlivxe nv6ol04
8 Apr 19
Proxy Statement - Annex A1
6:38am
6-K
as9u45a hzv
1 Apr 19
Report of Foreign Private Issuer
6:47am
6-K
y71p3klyfyqqjuckjs
22 Mar 19
Report of Foreign Private Issuer
4:30pm
6-K
576mxksknrm8
14 Mar 19
Notice of Special General Meeting of Shareholders
5:19pm
6-K
qjyda6u bp
14 Mar 19
Kitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology Company
9:28am
6-K
d1akqno 42tbv
11 Feb 19
Thank you CORPORATE PRESENTATION February 2019
4:47pm
6-K
ofm5tazxklzj
7 Feb 19
Kitov Pharma Reports Year End 2018 Financial Results and Provides Business Update
8:08am
6-K
tnt1gdv8 2j1y
18 Jan 19
Kitov Closes $6 Million Registered Direct Offering
5:22pm
6-K
c73vpuu4e asl
18 Jan 19
Report of Foreign Private Issuer
11:58am
6-K
hn84t2hjbmm8 b7
16 Jan 19
Kitov Announces Pricing of $6 Million Registered Direct Offering
4:05pm
6-K
sr9l36y4rq0eimbm
15 Jan 19
Report of Foreign Private Issuer
5:15pm
6-K
j0exg40lu9yys8p6m
3 Jan 19
Kitov Signs Marketing and Distribution Agreement for its Lead Product Consensiā¢ in the U.S. with Coeptis Pharmaceuticals
7:20am